Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Seelos Therapeutics stock

Learn how to easily invest in Seelos Therapeutics stock.

Seelos Therapeutics is a biotechnology business based in the US. Seelos Therapeutics shares (SEEL) are listed on the NASDAQ and all prices are listed in US Dollars. Seelos Therapeutics employs 16 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Seelos Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SEEL. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Seelos Therapeutics stock price (NASDAQ: SEEL)

Use our graph to track the performance of SEEL stocks over time.

Seelos Therapeutics shares at a glance

Information last updated 2023-02-02.
Latest market close$0.88
52-week range$0.48 - $1.52
50-day moving average $0.88
200-day moving average $0.87
Wall St. target price$6.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.61

Buy Seelos Therapeutics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Seelos Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Seelos Therapeutics price performance over time

Historical closes compared with the close of $0.88 from 2023-02-06

1 week (2023-01-31) 8.36%
1 month (2023-01-06) 12.12%
3 months (2022-11-07) 1.15%
6 months (2022-08-05) -12.00%
1 year (2022-02-07) -21.43%
2 years (2021-02-05) -73.81%
3 years (2020-02-07) 0.89
5 years (2018-02-07) 71.4

Seelos Therapeutics financials

Gross profit TTM $-46,649,000
Return on assets TTM -82.37%
Return on equity TTM -203.33%
Profit margin 0%
Book value $0.07
Market capitalisation $86.9 million

TTM: trailing 12 months

Seelos Therapeutics share dividends

We're not expecting Seelos Therapeutics to pay a dividend over the next 12 months.

Have Seelos Therapeutics's shares ever split?

Seelos Therapeutics's shares were split on a 1:30 basis on 23 January 2019. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Seelos Therapeutics shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Seelos Therapeutics shares which in turn could have impacted Seelos Therapeutics's share price.

Seelos Therapeutics share price volatility

Over the last 12 months, Seelos Therapeutics's shares have ranged in value from as little as $0.48 up to $1.52. A popular way to gauge a stock's volatility is its "beta".

SEEL.US volatility(beta: 1.96)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Seelos Therapeutics's is 1.9586. This would suggest that Seelos Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Seelos Therapeutics overview

Seelos Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York. .

Frequently asked questions

What percentage of Seelos Therapeutics is owned by insiders or institutions?
Currently 2.985% of Seelos Therapeutics shares are held by insiders and 28.084% by institutions.
How many people work for Seelos Therapeutics?
Latest data suggests 16 work at Seelos Therapeutics.
When does the fiscal year end for Seelos Therapeutics?
Seelos Therapeutics's fiscal year ends in December.
Where is Seelos Therapeutics based?
Seelos Therapeutics's address is: 300 Park Avenue, New York, NY, United States, 10022
What is Seelos Therapeutics's ISIN number?
Seelos Therapeutics's international securities identification number is: US81577F1093
What is Seelos Therapeutics's CUSIP number?
Seelos Therapeutics's Committee on Uniform Securities Identification Procedures number is: 652903105

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site